News About: Pharm. Industry
LG Life Science to launch Zanidip 20mg.LG Life Science has launched a new strength of Zanidip 20mg tablet, claiming that it has a double strength in its potency for 24 hour action.
LG said that Zanidip 20mg showed...
|
.jpg)
Abbott Korea to release Precision Xceed blood glucose monitorsAbbott Korea plans to introduce Precision Xceed blood glucose monitoring systems sooner or later.
Precision Xceed is an advanced diabetes management system that has the capab...
|
Asset of individual pharmaceutical stocks exceed 1 trillion won
An increasing number of individual pharmaceutical stocks have surpassed 1 trillion won, largely due to the recent bull run on the local bourse.
By asset, Yuhan Corporation topped the list with 1.8 trillion, followe...
Ilyang awaits approval for ilaprazole in China
Ilyang Pharm is soon expecting to receive marketing approval for ilaprazole, a new investigational proton pump inhibitor, from the Chinese drug regulatory agency (SFDA) after completing a local phase III clinical stud...
Hanmi to enhance services for doctors and pharmacists.Hanmi signed an MOU with Daeshin Security company for a joint marketing service to be rendered to doctors and pharmacists on Aug. 8.
Hanmi said "To boost a customer relation...
|
Pfizer Korea to hire 20 CRAs
Pfizer Korea said on August 8 that it plans to begin its official recruitment of 20 clinical research associates (CRAs) until August 24, as part of its efforts to substantiate its prior commitment to invest $300 milli...
Multinational drug manufacturers trim production in Korea
Foreign drug makers reduced production in Korea as the nation's major players like GlaxoSmithKline, Roche Korea and Wyeth Korea left the country to find better sites for their plants abroad.
According to ...
Multinational drug corporations now put major efforts for anticancer markets in Korea.
Major multinational drug corporations have not shown any intensive efforts for the anti-cancer drug markets but recently, GSK, for instance, has declared major promotional
activities initially by taking an occasion o...
Lilly Korea says KFDA approved Cymbalta, new anti-depressant.
Lilly Korea announced that the KFDA approved Cymbalta (duloxetine HCL), a new generation of anti-depressant drug, on July 30 for the treatment of major depressive disorders (MDD)
Cymbalta is an SNRI anti-depress...
CoQ10 bulk market slump continues
Co-enzyme Q10 (CoQ10) makers are expected to show their worst performances in the second quarter of the year, with only a slim hope of recovery in the near future.
Prices of CoQ10 have been stagnant since they reac...
